Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986517 in Advanced Solid Tumors
NCT07160725Phase 2Recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2025
- Primary completion
- Jul 2028
- Countries
- 5
01
Overview
A Phase 2 trial of BMS-986517 in solid tumor, sponsored by Bristol Myers Squibb. Started Oct 2025; status: recruiting.
02
Drugs
BMS-986517
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07160725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07160725.